David C. Paul
David Paul served as our Chief Executive Officer from our inception in 2003 until August 2017, when he transitioned into the role of Executive Chairman. Prior to founding Globus, Mr. Paul was employed at Synthes in various positions. He served as Director of Product Development for Synthes in his last position, where he was responsible for product development and marketing functions. Prior to Synthes, Mr. Paul worked as a Research Engineer in biomaterials research at Temple University. Mr. Paul is a named inventor on approximately 45 patents and 74 pending patent applications. Mr. Paul received a B.S. in Mechanical Engineering from the University of Madras, and an M.S. in Computer Integrated Mechanical Engineering Systems from Temple University.
David M. Demski
Chief Executive Officer
Dave Demski became Chief Executive Officer in August 2017. Between September 2015 and August 2017, Mr. Demski served as President, Emerging Technologies. Mr. Demski served as our President and Chief Operating Officer from August 2008 to September 2015 and as our Chief Financial Officer from 2003 to July 2008. Prior to joining Globus Mr. Demski founded Cornerstone Capital LBO Fund, a boutique leveraged buyout consultancy. Mr. Demski’s experience also includes serving as Vice President for Gilo Ventures, a Silicon Valley-based venture capital fund, and serving as Chief Operating Officer of Rendall and Associates, a telecommunications-focused consulting firm. He also managed regional and international distribution for Domino’s Pizza during the company’s growth in the late 1980s. Previously he was an audit supervisor for Peat, Marwick, Mitchell & Company. Mr. Demski received a B.S. in Business Administration from the University of Michigan and an M.B.A. from Stanford Graduate School of Business.
Daniel T. Scavilla
Senior Vice President and CFO
Dan Scavilla has served as our Senior Vice President and Chief Financial Officer since May 2015. Prior to joining Globus Mr. Scavilla spent 28 years in various financial management positions at Johnson & Johnson (JNJ). Where he served as CFO, Global Vice President Finance & Business Operations at JNJ’s Vision Care Division and prior to that served as Worldwide Vice President Finance of the Advanced Sterilization Products division of JNJ. Other prior roles at JNJ include financial management positions at McNeil Consumer Healthcare, Centocor Biologics, and Cilag Schaffhausen Operations in Switzerland. Mr. Scavilla received a B.S. in Finance from LaSalle University, and holds an MBA in International Management from Temple University.